Table 7.
Comparison of serum calcium values between the kanamycin-based group and the capreomycin-based group at the initial visit, first month, and second month of treatment.
| N | Calcium | p value | |||
|---|---|---|---|---|---|
| Mean ± SD (mg/dL) | Min-max (mg/dL) | ||||
| Initial visit | Kanamycin | 33 | 4.80 ± 1.04 | 3.89–10.33 | 0.839 |
| Capreomycin | 20 | 4.74 ± 0.37 | 4.26–5.61 | ||
|
| |||||
| First month | Kanamycin | 33 | 4.56 ± 0.39 | 3.69–5.16 | 0.434 |
| Capreomycin | 20 | 4.50 ± 0.23 | 4.05–4.94 | ||
|
| |||||
| Second month | Kanamycin | 33 | 4.65 ± 0.45 | 3.61–5.33 | 0.053 |
| Capreomycin | 20 | 4.43 ± 0.35 | 3.65–4.98 | ||
SD, standard deviation; min, minimum value; max, maximum value; analyzed using the unpaired t-test.